Avoro Capital Advisors LLC - 31 Dec 2025 SCHEDULE 13G Report for Definium Therapeutics, Inc. Common Shares, no par value per share

Filing Manager
Avoro Capital Advisors LLC
Reporting Manager
Avoro Capital Advisors LLC
Security
Definium Therapeutics, Inc. Common Shares, no par value per share
Shares outstanding
98,425,197 shares
Disclosed Ownership
5,000,000 shares
Ownership
5.1%
Form type
SCHEDULE 13G
Filing time
17 Feb 2026, 09:00:20 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Avoro Capital Advisors LLC 5.1% 5,000,000 5,000,000 0 /s/ Scott Epstein Scott Epstein, Chief Operating Officer and Chief Compliance Officer
Behzad Aghazadeh 5.1% 5,000,000 5,000,000 0 /s/ Behzad Aghazadeh Behzad Aghazadeh, Individually